Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression
Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression
Chronic inflammation increases the risk of cancer and many cancers, including prostate cancer, arise at sites of chronic inflammation. Inducible nitric oxide synthase (iNOS) is an enzyme dominantly expressed during inflammatory reactions. Although synthesis of high amounts of nitric oxide (NO) by iNOS has been demonstrated in pathophysiological processes, such as acute or chronic inflammation, autoimmune diseases or tumorigenesis, the role of iNOS activity in most of these diseases is poorly understood. Analysing prostate cancer biopsies by immunohistochemistry we found iNOS protein expression in tumor cells strongly paralleled by nitrotyrosine suggesting that iNOS is fully active. In vitro, NO inhibits androgen receptor-dependent promoter activity and prostate specific antigen production as well as DNA-binding activity of the androgen receptor (AR) in a concentration-dependent manner. Inhibition of the activity of androgen receptor-dependent reporter constructs is neither owing to diminished AR protein levels nor owing to an inhibition of its nuclear import. In addition, NO inhibits the proliferation of androgen receptor-positive prostate cancer cells significantly more efficiently than proliferation of androgen receptor-negative prostate cancer cells. In summary, our findings suggest that intratumoral iNOS activity favors development of prostate cancer cells that are able to proliferate androgen receptor-independently, thereby promoting prostate tumor progression.
androgen receptor, nitric oxide, prostate cancer, prostate specific antigen, zinc-finger
1875-1884
Cronauer, M.V.
af739358-e9c0-49ec-9005-b93768d8410e
Ince, Y.
d56dd2a9-f730-4ed5-a7d3-7cdfb825be9d
Engers, R.
3f154066-b626-4f54-8721-d03686f76148
Rinnab, L.
26323e74-2ecd-4e10-b6bd-ffc269f52f8a
Weidemann, W.
31f5ed8d-9044-4359-bd95-820342d9a50a
Suschek, C.V.
a03a2969-e2c1-40c4-a7fd-70f2bb4acd66
Burchardt, M.
a7143f1a-c4b1-46b1-b3a5-401ba15fa0f1
Kleinert, H.
15d40ccc-1b94-4b8c-a95b-08d93deaf4ff
Wiedenmann, J.
ad445af2-680f-4927-90b3-589ac9d538f7
Sies, H.
ac26d6d1-331f-48dc-903f-716d73d06dca
Ackermann, R.
5c67515e-db41-4515-8b98-3fe0b43aa45f
Kröncke, K.D.
c1d51a75-ffa1-4b72-a7b2-d4d8dc88f309
22 March 2007
Cronauer, M.V.
af739358-e9c0-49ec-9005-b93768d8410e
Ince, Y.
d56dd2a9-f730-4ed5-a7d3-7cdfb825be9d
Engers, R.
3f154066-b626-4f54-8721-d03686f76148
Rinnab, L.
26323e74-2ecd-4e10-b6bd-ffc269f52f8a
Weidemann, W.
31f5ed8d-9044-4359-bd95-820342d9a50a
Suschek, C.V.
a03a2969-e2c1-40c4-a7fd-70f2bb4acd66
Burchardt, M.
a7143f1a-c4b1-46b1-b3a5-401ba15fa0f1
Kleinert, H.
15d40ccc-1b94-4b8c-a95b-08d93deaf4ff
Wiedenmann, J.
ad445af2-680f-4927-90b3-589ac9d538f7
Sies, H.
ac26d6d1-331f-48dc-903f-716d73d06dca
Ackermann, R.
5c67515e-db41-4515-8b98-3fe0b43aa45f
Kröncke, K.D.
c1d51a75-ffa1-4b72-a7b2-d4d8dc88f309
Cronauer, M.V., Ince, Y., Engers, R., Rinnab, L., Weidemann, W., Suschek, C.V., Burchardt, M., Kleinert, H., Wiedenmann, J., Sies, H., Ackermann, R. and Kröncke, K.D.
(2007)
Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.
Oncogene, 26 (13), .
(doi:10.1038/sj.onc.1209984).
Abstract
Chronic inflammation increases the risk of cancer and many cancers, including prostate cancer, arise at sites of chronic inflammation. Inducible nitric oxide synthase (iNOS) is an enzyme dominantly expressed during inflammatory reactions. Although synthesis of high amounts of nitric oxide (NO) by iNOS has been demonstrated in pathophysiological processes, such as acute or chronic inflammation, autoimmune diseases or tumorigenesis, the role of iNOS activity in most of these diseases is poorly understood. Analysing prostate cancer biopsies by immunohistochemistry we found iNOS protein expression in tumor cells strongly paralleled by nitrotyrosine suggesting that iNOS is fully active. In vitro, NO inhibits androgen receptor-dependent promoter activity and prostate specific antigen production as well as DNA-binding activity of the androgen receptor (AR) in a concentration-dependent manner. Inhibition of the activity of androgen receptor-dependent reporter constructs is neither owing to diminished AR protein levels nor owing to an inhibition of its nuclear import. In addition, NO inhibits the proliferation of androgen receptor-positive prostate cancer cells significantly more efficiently than proliferation of androgen receptor-negative prostate cancer cells. In summary, our findings suggest that intratumoral iNOS activity favors development of prostate cancer cells that are able to proliferate androgen receptor-independently, thereby promoting prostate tumor progression.
This record has no associated files available for download.
More information
Published date: 22 March 2007
Keywords:
androgen receptor, nitric oxide, prostate cancer, prostate specific antigen, zinc-finger
Identifiers
Local EPrints ID: 51170
URI: http://eprints.soton.ac.uk/id/eprint/51170
ISSN: 0950-9232
PURE UUID: b72d4975-637d-49ef-858e-bbc66c20cc97
Catalogue record
Date deposited: 08 May 2008
Last modified: 16 Mar 2024 03:53
Export record
Altmetrics
Contributors
Author:
M.V. Cronauer
Author:
Y. Ince
Author:
R. Engers
Author:
L. Rinnab
Author:
W. Weidemann
Author:
C.V. Suschek
Author:
M. Burchardt
Author:
H. Kleinert
Author:
H. Sies
Author:
R. Ackermann
Author:
K.D. Kröncke
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics